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Trimeric HIV Env provides epitope
occlusion mediated by hypervariable
loops
Carlos G. Moscoso1, Li Xing1, Jinwen Hui1, Jeffrey Hu1, Mohammad Baikoghli Kalkhoran1,
Onur M. Yenigun1, Yide Sun2, Lassi Paavolainen3, Loı¨c Martin4, Anders Vahlne5, Carlo Zambonelli2*,
Susan W. Barnett2, Indresh K. Srivastava2{ & R. Holland Cheng1,5
1Department of Molecular and Cellular Biology, University of California, Davis, CA 95616, 2Novartis Vaccines and Diagnostics
Inc., 45 Sydney Street, Cambridge, MA 02139, 3Department of Biological and Environmental Science/Nanoscience Center,
University of Jyva¨skyla¨, FI-40351 Jyva¨skyla¨, Finland, 4Commissariat a` l’e´nergie atomique et aux e´nergies alternatives, Institut de
Biologie et Technologies de Saclay, Service d’Inge´nierie Mole´culaire des Prote´ines, Gif-sur-Yvette F-91191, France, 5Karolinska
Institutet, Structural Virology, Clinical Microbiology/University Hospital, 171 77 Stockholm, Sweden.
Hypervariable loops of HIV-1 Env protein gp120 are speculated to play roles in the conformational
transition of Env to the receptor binding-induced metastable state. Structural analysis of full-length
Env-based immunogens, containing the entire V2 loop, displayed tighter association between gp120
subunits, resulting in a smaller trimeric diameter than constructs lacking V2. A prominent basal quaternary
location of V2 and V39 that challenges previous reports would facilitate gp41-independent gp120-gp120
interactions and suggests a quaternary mechanism of epitope occlusion facilitated by hypervariable loops.
Deletion of V2 resulted in dramatic exposure of basal, membrane-proximal gp41 epitopes, consistent with
its predicted basal location. The structural features of HIV-1 Env characterized here provide grounds for a
paradigm shift in loop exposure and epitope occlusion, while providing substantive rationale for epitope
display required for elicitation of broadly neutralizing antibodies, as well as substantiating previous
pertinent literature disregarded in recent reports.
M
embrane fusion between HIV and host cells is mediated by the Env complex on the surface of the viral
membrane envelope1. The Env complex is comprised of three copies each of gp120 and gp41, arranged as
a trimer on the viral membrane2. The capacity of Env-based trimeric immunogens to elicit a broad and
potent immune response could provide a significant degree of protection against viral infection. Given the
propensity for distinct antibodies to preferentially target the trimeric form as opposed to monomeric gp120,
there is an impetus to characterize with fidelity the quaternary structure of Env-based immunogens so as to
pinpoint targets for rational immunogen design.
Previously, we showed that the structure of gp140DV2TV13 including a 30-residue truncation in the second
hypervariable (V2) loop4–6 had a concave apex and a depressed trimeric center, a view supported by recent
cryotomography and cryoelectron microscopy (cryoEM) work7–9. Recently, an alternative architecture of the
Env complex has been put forth10–12, with a large cap at the trimeric apex that houses the V2 and V3 hypervariable
loops. Such an arrangement does not take into consideration the myriad studies suggesting close association
between gp120 and gp4113–19; instead, these recent publications suggest that there is only minimal gp120-gp41
interaction, limited to the N- and C-termini. Further, the recent publication of the structure of a clade A strain
BG505 SOSIP gp140 trimer in complex with the Fab of PGV0420, accompanied by a crystal structure of the same
gp140 in complex with PGT122 Fab21 agree with the apical cap view of trimer arrangement. However, another
recent cryoEM structure of a clade A strain KNH1144 SOSIP trimer in complex with the Fab of the 17b antibody
again shows a marked lack of trimeric ‘‘cap’’ apex and thus the lack of cavity. Amore recent article from the same
group22 indeed claims that the presence of a large cavity in the center of the trimer is likely an artifact due to
limited resolution, and indeed shows a convex apex with no cap in the native, ‘‘closed’’ quaternary state.
Our current results challenge the prevailing perspective, and posit that instead of being situated at the trimeric
apex, the V2 loop is situated at the basal region of the trimer, oriented toward the adjacent gp120 subunit and
associating with that subunit’s V3 loop, forming the quaternary neutralizing epitope (QNE). Indeed, exactly how
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juxtaposed V2 and V3 loops from the same subunit, a tertiary epi-
tope, would form the basis for the QNE, preferentially recognized on
trimeric Env8,23,24 is difficult to ascertain. Further, other corroborat-
ing data, including increased exposure of gp41 upon V2 deletion25,26,
increased V39 exposure following V2 deletion6,27,28, and increased
exposure of V429–31, all support our model of apical V4 exposure
and basal V2 location, with interprotomeric contacts between V2
and the adjacent V39. Our model also paints an indirect role for
V2 in CD4 binding site (CD4BS) occlusion, as observed in several
reports6,32–36; by engaging the adjacent subunit, the interprotomeric
contacts decrease the trimeric diameter, and thus decrease apical
accessibility to the CD4BS, in contrast to the current view of direct
steric blockage of the CD4BS by a solid cap containing hypervariable
loops.
Biochemical and structural characterization of the recombinant,
soluble trimeric immunogen gp1403,5,34,37 has yielded results dem-
onstrating that deletion of the V2 loop enhances binding of
CD4BS-targeting antibodies, and slightly increases CD4 binding,
suggesting that V2 may be involved in occlusion of the CD4BS.
The V2 loop can acquire length, a finding correlated with enhanced
viral escape from host immune responses38. Our recent structure of a
clade C gp140 immunogen with a partial, 30-residue V2 deletion
suggests that the quaternary location of the V2 loop is proximal to
the viral membrane, and oriented toward the adjacent counterclock-
wise gp120 subunit3. The V2 loop has also been implicated in forma-
tion of a quaternary epitope formed by V2 and V39 that is
preferentially recognized in Env trimers by broadly neutralizing anti-
bodies (bNAbs) PG9 and PG1624 and 290939, which have recently
been structurally characterized8,40. However, the formation of such
an epitope in the quaternary context remains to be investigated.
Attempts at elucidating the structure of the Env complex to under-
stand its mechanism of action have yielded disparate results with no
clear consensus8,41–45. Earlier tomograms of membrane-embedded
Env trimers suggested that the V2 loop was located at a region prox-
imal to the viralmembrane at the base of the trimeric spike41,42, as was
also proposed in trimeric modeling of the SIV gp120 monomeric X-
ray structure46. More recent tomography structures of membrane-
embedded trimers have suggested that the location of the V2 loop is
at the trimer apex ‘‘cap’’8,43,45. A more striking example of this
apical ‘‘cap’’ followed in the description of Env spikes extracted from
detergent-treated virions10,12. Structures of clade A and B gp140
immunogens dispelled at least in part the notion of a closed cap at
the trimer apex, but showed little to almost no density associating the
three gp120 subunits in one structure7. More recent SIV spike cryo-
tomograms from the same group47 revert back to the ‘‘cap’’ over the
threefold axis, while also claiming an ‘‘open’’ state. Such structural
interpretations of an apical V2 quaternary location are inconsistent
with studies using biochemical16,18 and scanning mutagenesis meth-
ods14,15,17,19, and as such, the location of V2 remains unresolved.
Here we present the structures of a clade C trimeric, full-length
soluble gp140 immunogen from the TV1 strain in the absence and
presence of the CD4-mimetic miniprotein CD4m48, and compare
these structures to our previous study of immunogens with a partial
V2 truncation3. The quaternary arrangement hints at a mechanism
for epitope occlusion that may offer pertinent insight into gp41-
independent gp120-gp120 interactions.
Results
Full-length gp140 reconstructions with and without CD4m.
Isosurface rendering of the gp140TV1 (hereinafter gp140) density
map showed that the trimer structure retained the propeller-shaped
motif that gp140DV2 exhibited (Figs. 1A, 1C). The three subunits of
gp120 displayed clockwise handedness, a pointed gp41 hub, and
dimensions of 100 A˚ in diameter and 125 A˚ in height, taller than
that of the gp140DV2 trimer (Figs. 1C). While retaining a congruent
overall morphology, there are a few key differences between the
constructs, aside from the slight difference in molecular weight
(Fig. 1B, 1D). The gp140DV2 density map was approximately 90 A˚
in height, while the gp140 density map is about 125 A˚ in height.
Another important difference is the smaller degree of tilt away
from the threefold z axis; the gp140DV2 construct shows gp120
subunits at a tilt of approximately 25u, whereas the gp140
construct exhibits a tilt of about 15u–20u. A more relevant feature
is the presence of a tail-like density at the putative location of the V2
loop (Fig. 1C, 1E). Two distinct densities at the location of the V2
loop can be seen, pointing in opposite directions, and likely
displaying the branched, adjacent V1/V2 loops. Additionally, the
center trimeric region was also similar to that of gp140DV2,
suggesting that this region anchors the three subunits to the
central stalk. If each gp120 subunit is assigned a long axis through
Figure 1 | Structure of full length gp140. (A) Raw cryoelectron micrograph of gp140. Arrows point to particles embedded in vitreous ice. (B) Sequence
alignment of gp140 and gp140DV2, showing 30-residue deletion near tip of V234. (C) Top and side views of gp140 exhibit a clockwise handedness and
protrusions from the basal trimer regions. Resolution is ,21 A˚ at 0.5 FSC. (D) SDS-PAGE of gp140 and gp140DV2, with molecular weights at
approximately 140 kDa. (E) Detail in (C) bottom panel, accentuating protruding densities at base of gp140 assigned to V1 and V2 loops.
www.nature.com/scientificreports
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the molecule at 90u, 210u and 330u (S1, S2 and S3, respectively), all
normal to the threefold z axis, then each subunit would appear tilted
away from the z axis about the Sx axis by ,25u, similar to the
unliganded gp140DV2 structure. The three gp120 regions appear
to be more closely associated near the trimer apex, with density at
the outermost tip of each gp120 subunit oriented toward the
threefold axis. The wedge-shaped trimer arm region is quite
consistent when compared to the gp140DV2 map.
Presence of V1/V2 density proximal to viral membrane.
Comparative analysis of both maps places the location of V2 on
the outer edge of each trimer fan blade proximal to the viral
membrane, supporting our earlier docking of coordinates in the
gp140DV2 density map (Fig. 1E). The V1 loop faces the adjacent
clockwise subunit, whereas the V2 loop would be in a position
proximal to the adjacent counterclockwise subunit, likely
mediating gp41-independent gp120-gp120 interactions. The V1/
V2 loops appear as a branched pair of densities facing in opposite
directions. The density attributed to V1 is ,38 A˚ in length, and the
density corresponding to V2 is about 45 A˚. These dimensions
correspond well with the length expected from the number of
residues in each loop.
Immunogold labeling of gp140 reveals basal V2 andV39 locations.
Conjugation of gold-labeled PG16 Fab9 fragments with trimeric
gp140 followed by single particle reconstruction of gp140-PG16
complexes revealed a density protruding from the basal V2
location (Fig. 2A). The gp140-PG16 map confirmed the basal
location of V2, as well as the interprotomeric location of the QNE.
Superimposition of the gp140 unliganded map with the gp140-PG16
map confirmed the basal protruding density apportioned to V2, as
well as additional density assigned to the PG16 Fab (Fig. 2B).
Accessibility of gp41 epitopes upon V2 deletion by western blot
and ELISA. In order to determine the relative accessibility of apical
or basal gp41 epitopes as a function of V2 deletion, we probed full-
length and DV2 gp140 constructs with anti-gp41 antibodies
targeting apical (50–69, targeting the intrahelical disulfide-
containing loop) and basal (2F5, targeting the membrane-proximal
external region) epitopes by western blot. There were no differences
in 50–69 epitope accessibility between full-length and truncated
gp140, while there was a marked difference in accessibility to 2F5
epitope, with full-length gp140 shielding the epitope and gp140DV2
displaying increased access to it (Fig. 2C). Epitope access between
constructs was also determined utilizing the same antibodies by
ELISA (Fig. 2D), with similar results.
Comparison of gp140 maps before and after CD4m conjugation.
The gp140 map was conjugated with CD4m, and the morphology of
the trimer in the CD4m-triggered state was quite consistent with our
previous observations. The diameter of the triggered map remains at
110 A˚, while the height is 80 A˚, amarked reduction in height from the
unliganded form resulting from subunit tilting away from the z-axis
(Fig. 3A). There is a pronounced dissociation away from the
threefold axis, and the interaction between each trimer arm and
the trimeric center is quite weakened. Rotation of subunits about
axes perpendicular from the z-axis result in a previously occluded
face on each subunit being newly exposed for perpendicular access
(Fig. 3A).
Figure 2 | Structure of gp140-PG16 complex reveals basal V2 location, and deletion of V2 results in exposure of basal gp41 epitopes as detected by
western blot and ELISA. (A) The gp140 trimer was incubatedwith PG16 Fab and imaged by cryoEM. Structure of the gp140-PG16 complex reveals a basal
density emanating from the putative location of the V2 loop (red). Resolution is,26 A˚ at 0.5 FSC. (B) Superimposition of the gp140 unliganded map
(solid) and the gp140-PG16 complex (mesh) reveals that binding of PG16 occurs at the basal V2 density (red mesh). (C) Western blot of gp140 and
gp140DV2 constructs labeled with antibodies 50–69 and 2F5, targeting apical and basal gp41 epitopes respectively, shows that exposure of the 50–69
epitope (targeting the intrahelical disulfide-containing loop on gp41) is unaffected by V2 deletion, while 2F5 epitope exposure (targeting the gp41
membrane-proximal external region) is greatly enhanced after V2 deletion. Blots shown are representative results. (D) ELISA of gp140 and gp140DV2
bound to 50–69 and 2F5 similarly reveal that while 50–69 epitope exposure is unaffected by V2 deletion, 2F5 epitope exposure is significantly enhanced by
V2 deletion (n 5 3).
www.nature.com/scientificreports
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Gp120-gp41 interface diminution, outward density shift and
gp120 domain coalescence. We performed preliminary 2D
analysis of gp140 bound to CD4m, and confirmed our earlier
results of an outward interface diminution. By taking class
averages showing top views of both unliganded and CD4m-
liganded gp140 (Fig. 3A), and taking cursor profiles of class
averages through the gp140 arms, a decrease in intensity in the
CD4m-conjugated structure corresponding to the gp120-gp41
interface is apparent when compared to the unliganded gp140
map. The density diminution was confirmed by analyzing slices of
the gp140 unligandedmap and the gp140-CD4mmap (Fig. 3B), with
a clear gap in high intensity voxels at the gp120-gp41 interface in the
CD4m-bound map.
A higher level of detail was gleaned from comparative analysis of
the two density maps by slicing through the volume, with distinct
subunit domains evident from density gravity centers (Fig. 3C).
Previously, distinct and discrete density peaks present within the
volume attributed to gp120 suggested a separation between domains
on gp120. The current map of gp140 also shows a similar density
separation when slicing through the volume; this finding corrobo-
rates the initial observations of domain separation described for the
gp140DV2 density map (Fig. 3C). Also, the inner and outer domains
of gp120 in the trimer arms were shown to coalesce following CD4
binding, agreeing with our earlier observation (Fig. 3C).
Comparison of gp140 and gp140DV2 maps reveal a gradient of
‘‘open’’ states mediated by both V2 deletion and CD4m binding.
The gp140 and gp140DV2 maps, with and without CD4m, were
determined to have a gradient of gp120-gp41 interface ‘‘open’’
states, as determined by the extent of intensity at the interface
region. The unliganded gp140 map had the strongest interface
between gp120 and gp41 observed of all four maps, followed by
the gp140DV2 map, then the gp140-CD4m and lastly the
gp140DV2-CD4m map (Fig. 4A). As such, it appears that both the
V2 loop and CD4m binding contribute to the degree of ‘‘open’’ state,
putatively exposing novel epitopes at the gp120-gp41 interface
region. Given the propensity of V2 to promote interprotomeric
gp120-gp120 contacts via the QNE, we also observed a smaller
trimeric diameter when comparing the gp140 and the gp140DV2
maps. The trimeric diameter remained unchanged between the
gp140DV2, gp140-CD4m and gp140DV2-CD4m maps, resulting
from the outward density shift promulgated by CD4m binding
(Fig. 4A). Likewise, we observed that the smaller trimeric diameter
is apparent in other clade C trimers, namely from the
CAP45.2.00.G3, CAP239.2.00.G3J and Du156.1 strains (Fig. 4B).
Measurements of trimeric diameter of DV2 compared to full-
length strains revealed that the full length strains had smaller
trimer diameters (99 to 103 A˚) compared to DV2 (110 A˚).
Location of V3 & V4 loops, CD4 binding angles. Coordinates of
unliganded gp120 (PDB 2BF1, SIV) were docked into the density
map, resulting in good agreement (correlation coefficient of 0.79)
(Fig. 5A–C). The coordinates varied only slightly from the docking
position in the gp140DV2 trimer. The location of the truncated V2
loop in the coordinates corresponds again to the visible densities
emanating from this location. Coordinates of CD4m-bound gp120
(PDB 2I5Y, HIV-1) were docked into the gp140-CD4m map, again
with good agreement (correlation coefficient of 0.77). Docked
coordinates agreed well with our previous docking in the CD4m-
bound state, with the CD4BS oriented facing the adjacent counter-
clockwise subunit.
The V3 loop is situated on the inner face of the gp120 subunit
trimer fan blade, facing the adjacent clockwise gp120 subunit.
Adjusting the contour to,0.75 s above the mean intensity revealed
a tail-like density protruding from the putative location and extend-
ing toward the neighboring clockwise gp120 subunit. The density
attributed to this loop appears to be in close proximity to the V2
loop from the adjacent subunit (about 35 A˚ apart), close enough to
Figure 3 | Comparison of gp120-gp41 contacts and inner-outer domain separation in full length gp140 and gp140DV2. (A) 2D analysis of gp140 and
gp140-CD4m class averages by cursor profile reveals distinct weakening of gp120-gp41 interface region, as exemplified by graph at bottom (arrow). The
cursor profiles weremeasured from the center of the trimer outwards to the edge of the circularmask. Oblique views of unbound gp140 (top) and CD4m-
bound gp140 (bottom) reveal trimeric flattening and subunit rotations elicited by ligand binding. Scale bar 5 50 nm. Resolution of gp140-CD4m
structure is,26 A˚ at 0.5 FSC. (B) Top: Density map of gp140 shows a strong interface between gp120 and gp41. Bottom: Density map of gp140-CD4m
complex shows largely diminished gp120-gp41 interface. (C) Slice through gp140 structure (top) shows a density separation, likely representing the inner
and outer gp120 domains, while slicing through gp140-CD4m (bottom) shows a collapse of domains, without discernible gap between inner and outer
domain.
www.nature.com/scientificreports
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ostensibly be accessible by one Fab fragment. Such a quaternary
epitope would constitute increased intersubunit gp120-gp120 inter-
actions when compared to the gp140DV2 construct, resulting in the
decreased trimer radius. The V4 loop appears to be situated near
the trimer apex (Fig. 5A–B), with its multiple asparagine residues
likely contributing to increased electron density at this region.
Additionally, the V1 loop appears to emanate from the same face
of gp120 as the V3 loop, though from a location proximal to the viral
membrane. The V1 and V3 loops are also about 40 A˚ apart, and the
measured volumes of the V1, V2 andV3 loops at 0.75s are 20640 A˚3,
15870 A˚3, and 12250 A˚3, respectively. The density map of gp140
reaffirms our previous findings suggesting that the CD4 binding loop
(encompassing primarily residues 368–370) is perpendicularly
exposed and thus available for receptor binding (Fig. 5B).
2D segmentation of unliganded andCD4m-ligandedmaps reveals
structural malleability of variable loops. To determine the rigidity
of variable loops, we computed 2D histograms based on gradient
intensity of voxels, so as to visualize structurally stable core regions
of the trimer as well as more structurally labile regions. Taking the
derivate of intensities can augment detection of the solvent-protein
interface, as well as differentiate between structurally rigid and labile
regions. Taking regions from the 2D histogram, corresponding to a
fixed contour at different gradient intensity values, revealed distinct
density profiles not observed by traditional 1D volume histogram
cutoffs. The gp140 unliganded, 2D-segmented map revealed that
the protruding basal regions as well as the apical region were
present at low gradient intensities but not at higher gradient
intensities (Fig. 5D), revealing a core central density that remained
at higher regions in the 2Dhistogram. The top view of the unliganded
full-length gp140 map after 2D segmentation, at two different
gradient intensities (Fig. 5D), revealed close proximity of variable
loops at lower gradient intensity, indicative of close intersubunit
interactions mediated by structurally labile hypervariable loops.
Discussion
The location of the V2 loop presented herein, substantiating our
previous work, suggests that V2 indirectly occludes the CD4BS
through steric clashes of V4 glycans at the trimeric apex, near the
three binding sites for CD4, through intersubunit association with
the neighboring subunit’s V39 loop. Biochemical evidence of gp41
epitope accessibility upon V2 deletion corroborates our finding that
while apical gp41 exposure is unaffected, V2 deletion results in expo-
sure of basal gp41 epitopes targeted by mAb 2F5.
The juxtaposition of V2 and V39 loops from different subunits
explains why partial deletion of V2 confers enhanced CD4 binding
capability6; by associating with each other, the V2 and V39 loops
mediate closer intersubunit interactions and decrease the trimeric
diameter, reducing accessibility to the trimer apical regions including
the CD4BS. Earlier studies describing altered binding properties of
gp140 upon partial V2 deletion5,6,33,34 substantiate our quaternary
location of the V2 loop in association to the enhanced exposure of
neutralizing antibody (NAb) epitopes. Our current structure not
only shows protruding density from the base of the gp120 subunits
proximal to the viral membrane, populated by the V1/V2 loops
(Fig. 1E), but also resolves the bifurcation between the V1 and V2
loops. Deletion of the V2 loop increases exposure of the gp41 mem-
brane proximal external region (MPER)25,26, agreeing with our
observed structural feature that V2 is proximal to the viralmembrane
and would sterically hinder access to the gp41 MPER.
Figure 4 | Schematic representation of gp140 demonstrates intersubunit associations, relaxation of trimeric diameter upon deletion of V2. (A) The
gp140 trimer was compared with the gp140DV2, gp140-CD4m and gp140DV2-CD4m maps. The degree of gp120-gp41 interface strength appears to
decrease as a function of both V2 deletion and CD4m conjugation, with the gp140DV2-CD4mmap representing the most ‘‘open’’ state. Inclusion of the
V2 loop also results in a smaller trimeric diameter (100 A˚), though the diameter remains unchanged in the gp140DV2, gp140-CD4m and gp140DV2-
CD4m maps (110 A˚). (B) 2D comparison of gp140DV2TV1 with full length constructs gp140TV1, gp140DU156.1, gp140CAP239 and gp140CAP45
reveals that full length constructs all had smaller trimeric diameters (99–103 A˚) than gp140DV2TV1 (110 A˚), indicative of closer intersubunit associations
in full-length constructs than in DV2 constructs. Scale bar 5 75 A˚.
www.nature.com/scientificreports
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The current density map, with the wedge-like gp120 subunit
densities amenable to docking of unliganded coordinates, again cor-
roborates our previous docking orientation, such that CD4
approaches the trimer at an angle of approximately 60u–90u from
the horizontal plane (Fig. 5B). The exposed nature of the CD4BS
would facilitate CD4 binding, while the heavily glycosylated face
on V4, putatively at the trimeric apex, would guide the CD4 receptor
toward the immunogenic and conserved CD4BS.
A recent report onMoloneymurine leukemia virus, another retro-
virus, indicates that Env undergoes subunit rearrangement following
furin cleavage49. The finding that laterobasal protrusions are present
in mature, cleaved forms of the virus, while apical densities are pre-
sent in uncleaved, immature virus, bolster our findings that basal
protrusions assigned to hypervariable loops are present in mature
HIV-1 Env spikes.
The V39 loop protrudes laterally toward the adjacent clockwise
gp120 subunit and V2 loop, thus providing a footprint for QNE-
recognizing antibodies such as PG16 and 290924,39. The location of
V39 subsequent to CD4 binding renders it perpendicularly exposed,
as previously suggested3,43. Such a gp120 subunit rotation about an
independent axis would expose the cryptic CD4i epitope, and
thereby could also abrogate intersubunit V2-V39 contacts, contrib-
uting to the induced ‘‘open’’ conformation3.
The locations of V2 and V39 on gp120 in the trimeric context
appear to preclude the possibility of their joint accessibility on a
single gp140 protomer, where the tips of V2 and V3 are found
upwards of 60 A˚ apart, as observed from PDB coordinates 2B4C50.
Introducing a PNGS to the V2 loop of SF162 gp140 (K160N) allows
PG16 to bind with high affinity in either the monomeric or the
trimeric forms51. The juxtaposition of V2 and V3, demonstrated here
in the trimeric form, ismuchmore feasible to provide the binding site
for PG16 based on two adjoining protomers.
The V3 loop is occluded in the trimeric form of Env52, and pro-
teolytic susceptibility is induced upon CD4 binding53. Moreover,
deletion or mutation of V2 confers an increased immune response
toward V354. Such observations indicate that associations between
Figure 5 | Docking of coordinates into gp140 and gp140-CD4m density maps and location of epitopes, and 2D segmentation of unbound gp140 map.
(A) Side view of gp140 structure with SIV unliganded gp120 X-ray coordinates (PDB: 2BF1) docked. V1/V2 stem is in magenta, CD4 binding site is red,
and V4 loop is green. Arrows point to potential N-linked glycosylation sites on V4 near the trimer apex. Solid surface represents predominant density,
with weaker density shown in mesh. Scale bar5 50 A˚. Dashed rectangle outlines detail shown in (C). (B) Likely binding orientation of CD4 (yellow) to
gp140. Note the restricted accessibility to the CD4BS conferred by density near the threefold, attributed to heavy glycosylation in the V4 region.
Arrows are shown in same orientation as in (A). (C) Juxtaposition of the truncated V1/V2 loop stem with the bifurcated density proximal to the viral
membrane confirms our earlier V2 location. Arrow points to V1/V2 stem, as V1/V2 was truncated from the coordinates. (D) 2D segmentation of
unbound gp140 map at low gradient magnitudes (mesh) and high gradient magnitudes (solid), from a top view, reveals that the variable loop regions at
the base of the trimer disappear when map is visualized at high gradient intensities, suggesting that these regions are structurally malleable and not rigid.
Core of the protein at the center is evident at high gradient magnitudes, suggesting that there is little change in voxel intensity rate of change defining the
core of the structure, as opposed to the variable loops. At right, the proximity of the basal V2 (red) and apical V3 (green) promote intersubunit contacts,
decreasing trimeric diameter in the unliganded state. (E) Model of quaternary effects of V2 deletion and CD4m binding. At left, the full length trimer
shows a robust gp120-gp41 interface and interprotomer interactions between V2 and V39 loops. The gp120-gp41 interface is partly diminished following
V2 deletion, while interprotomer contacts are abrogated, resulting in a relaxed trimer with a larger diameter. Binding of CD4/CD4m results in further
weakening of the gp120-gp41 interface, subunit rotation (as exemplified by the rotated CD4BS), and enhanced exposure of the V3 loop.
www.nature.com/scientificreports
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V2 and V39 result in V39 occlusion in the unliganded trimer, as well
as the subsequent quaternary rearrangements we previously
reported3.
The location of V4 herein presents an alternative to current views
that V2 dominates the apical trimer region. Glycosylated asparagines
in V4 could provide the immunologically silent face55 necessary for
immune evasion, and the location of these CD4BS-proximal glycans
could provide a selective evolutionary advantage to HIV-1 virions
presenting a recessed conserved primary epitope, as opposed to
hypervariable loops comprising a cap over the trimer center.
Although acquisition of length in the V2 loop has been correlated
with neutralization resistance38, it is unlikely that a cap already
formed at the trimer apex would gain neutralization resistance from
increased length. A more likely scenario is that the degree of neut-
ralization resistance observed in Env trimers with increased V2
length38 is conferred due to intersubunit gp120-gp120 interactions,
with the longer V2 increasing contacts with the adjacent V39 loop. In
this scenario, V4 would be apically located, with the clade C gp140
construct including up to six PNGSs on and proximal to V4, which
are represented by the increased density near the threefold axis
(Fig. 5A–B). Given that V4 has been shown to elicit some of the
earliest antibody responses56, its apical location corroborates pre-
vious observations that modifications of PNGSs in V4 are significant
during HIV-1 adaptation to a novel host57.
A large site of immune evasion at the V4 andV5 locations has been
identified58, which is heavily glycosylated and orients the immune
response toward V3. Chen and colleagues point out that the bridging
sheet forms aberrantly upon binding to b12, F105 and b1358, and that
this bridging sheet abrogation may play a part in the potently (b12)
and weakly (F105 and b13) neutralizing ability of these antibodies.
Further, the observation that the V4 loop is involved in early auto-
logous NAb response in HIV-1 subtype C-infected patients56 is an
indicator that this region is likely highly exposed in the Env trimeric
complex.
In contrast to earlier tomographic Env structures, recent struc-
tures of clade A and B gp1407 agree much better with the structural
features of our current gp140 and previous gp140DV23, in which the
trimer apex does not contain a cap but rather displays concavity and
clear separation between the gp120 subunits at the threefold axis.
Similarly, Harris and colleagues recently drew on our earlier report of
gp140DV23 and reported evidence of a ‘‘closed’’ native conformation
and an ‘‘open’’ triggered conformation. Their findings, though sug-
gesting a solely quaternary event of trimeric conformational
rearrangement, do not take into account the extensively reported
gp120 tertiary conformational change and CD4-induced epitope
presentation; instead, a rotation moving the V2 loop away from
the threefold axis seems sufficient to delineate between the native,
‘‘closed’’ state and the CD4-triggered ‘‘open’’ state. Our structures
reveal features that account for the conformational change in gp120
outlined by X-ray structures of gp120 in the unliganded state46 and in
the CD4-bound state59. More recent examples of gp140 in the
‘‘closed’’ state that virtually abandon the heavy apical ‘‘cap’’ in favor
of a concave apex, in line with our observations, have been recently
reported22. Lastly, recent cryoEM and crystal structures of a clade A
SOSIP trimer with a truncated MPER show elements of the apical
cap, without the large central cavity20,21, though it is plausible that
glycosylation at the apex may have confounded residue assignment
in this region. Further differences between the gp140-PGT122 and
gp140-PGV04 complexes and our native structure include the
absence of a stalk-like gp41 region, which may be due to the
MPER truncation present in the BG505.664 construct, and its full
inclusion in the gp140TV1 construct. The position of V2 and V3 at
the apex of the BG505.664 trimer structures does not deviate from
our findings in the elicited, CD4-bound conformation, in which the
V2 and V3 loops occupy a more apical location; our observations are
that in the native, unliganded state, not shown in the BG505.664
structures, the V2 loop occupies a basal location that partially shields
gp41.
Conclusion
The ability of oligomeric gp140 to elicit NAbs with potency and
breadth, outlining its feasibility as a vaccine candidate, has been a
point of debate. Clade B gp140SF162 immunogens with a 30-residue
deletion in the V2 loop33 have several strong components, namely a
trimeric arrangement, ability to bind to potent NAbs and CD4i anti-
bodies affinity approximating wild-type Env, glycosylation profiles
closely mimicking wild-type Env, and similar CD4 binding capabil-
ity, all pointing to gp140 as a viable vaccine candidate. The use of
trimeric, recombinant soluble immunogens was partly validated by
the observation that gp140DV2SF162 was capable of eliciting potent
NAbs in a phase I clinical trial60, as well as by recent reports that
boosting with trimeric gp140 proteins increased antibody titers in
non-human primates61 and that trimeric gp140 elicits more potent
and broad NAbs than monomeric gp12023. Recent reports of unli-
ganded gp120 core constructs exhibiting the same conformation as
CD4-bound gp12062 are recognized, which illustrate the importance
of V2 and V3 in conformational modulation.
We present the structure of a full-length, clade C trimeric gp140
immunogen, and compared this structure to our previous structure
of a clade C gp140 trimer with a partial V2 deletion3. A model was
formulated through which V2 mediates gp41-independent gp120-
gp120 contacts, decreasing the trimer diameter and occluding crucial
gp120 epitopes. Additionally, we identified the juxtaposition of vari-
able loops from different gp140 subunits, which provide the QNE
that is preferentially targeted by antibodies such as PG16 and
290924,39. Evident from our study, the V2 loop renders crucial con-
served epitopes unexposed to the immune system by indirectly
shielding the CD4BS and other epitopes, as well as by forming the
QNE between the hypervariable loops from two adjacent subunits.
Combined with the closely clustered glycosylation on the V4 loop at
the trimer apex, the full-length V2-mediated Env conformation pro-
vides a significant degree of protection and evolutionary advantage to
dispel attempts at elicitation of potent and broad NAbs.
Methods
Methods to purify gp140 have been described elsewhere34. Briefly, Chinese hamster
ovary cells expressed gp140 after transfection, and soluble gp140 trimers were puri-
fied using a Galanthus nivalis agarose lectin column, a diethylaminoethyl column,
and a hydroxyapatite column, sequentially, in order to achieve high purity (.95%).
Methods to image soluble gp140 trimers embedded in vitreous ice using cryoelectron
microscopy have also been described previously3. Reconstruction, docking and
interpretation of resultant gp140 density maps were done in the same manner3.
Purification and sample preparation of gp140. The characterization and
purification of subtype C, full-length oligomeric gp140 was performed in the same
manner as gp140DV23,34. Briefly, gp140 was expressed in Chinese hamster ovary cells
and purified to homogeneity using a four step chromatography purification protocol.
First, a Galanthus nivalis agarose (GNA) lectin column was used to capture the
glycosylated Env construct, followed by a diethylaminoethyl (DEAE) column to
capture acidic proteins and nucleic acids. A ceramic hydroxyapatite (CHAP) column
was used to capture contaminating proteins while Env flowed through, and size
exclusion chromatography isolated the trimeric form. Samples were prepared on
holey carbon grids as previously described3,37, with a solution concentration of
0.1 mg/ml. Solutions of gp140 were diluted with Tris buffer (20 mM, pH 7.9) and
50 mM NaCl was added. Incubation of gp140 at 0.1 mg/ml with CD4m in excess
concentration (1051molar ratio) was done overnight at 4uC. The CD4mminiprotein
is a 27-residue CD4 mimicking peptide based on a scyllatoxin scaffold48, which has
been shown to elicit a nearly identical gp120 conformation as CD463. Additional
gp140 strains CAP45.2.00.G3, CAP239.2.00.G3J and Du156.1 were prepared by
similar methods and graciously provided by Jonathan Heeney (University of
Cambridge, UK).
Gold conjugation to Fab9 fragments and incubation with gp140. The antibody
PG16, preferentially targeting V2 but also V3 to a lesser extent, was provided by the
NIH AIDS Reagent Program. PG16 was digested using a Pierce Fab9 digestion kit
(Thermo Fisher Scientific Inc., Rockford, IL) and conjugated to 1.4 nm gold
fragments NanogoldH (Nanoprobes Inc., Yaphank, NY). PG16 was digested to
F(ab9)2 fragments, reduced using 50 mM Tris(2-carboxyethyl) phosphine
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hydrochloride (TCEP, SigmaAldrich, St. Louis,MO) for 10 min to yield reduced Fab9
fragments, and conjugated to gold particles for 30 mins, following manufacturer’s
protocol. The Fab9-gold conjugates were incubated with gp140 at a molar ratio of 351
at 4uC overnight.
Cryoelectron microscopy and particle selection. Samples in vitrified ice were
imaged using a JEOL 2100F field emission electron microscope at 200 kV, with an
electron dose of approximately 15 e2/A˚2. For the native state, 113micrographs and 64
micrographs for the CD4m-bound state were recorded at 80,0003 magnification
(Fig. 1A) and used for single particle reconstruction with the EMAN software
package64. Roughly 3300 individual native particle images were selected by a semi-
automated particle selection protocol, as well as 4800 particles for the CD4m-bound
structure. For the PG16-bound reconstruction, 2300 particles were selected and
classified for reconstruction.
Image processing, three-dimensional reconstruction and docking of X-ray
coordinates. Phase contrast transfer function (CTF) correction was performed using
ctfit in EMAN. The resultant particles were centered by autocorrelation, bandpass
filtered, and submitted for refinement, as previously done3,37. The density map had
previously published X-ray coordinates of SIV gp12046 docked into it using UCSF
Chimera65 and Situs66. Improvement of resolution was achieved by systematic
elimination of low-quality factor particles from refinement.
Western blot and ELISA. Western blots were performed by incubating gp140 and
gp140DV2 at 0.3 mg/ml with 50–69 and 2F5 antibodies (NIH AIDS Reagent
Program) at 2 mg/ml, transferring to PVDF membrane overnight, blocking with 5%
milk for 3 h, then washing in 0.1 M PBS-T 3X. The gp140-2F5, gp140DV2-2F5,
gp140-50-69, and gp140DV2-50-69 complexes were then incubated in anti-human
alkaline phosphatase-conjugated secondary antibody (Life Technologies, Grand
Island, NY) diluted 15500 for 1 h, washed in 0.1 M PBS-T, and the membranes were
developed in SIGMAFASTTM BCIPH/NBT (Sigma-Aldrich, St. Louis, MO).
ELISAs were conducted on 96-well plates by adsorbing gp140 at 0.3 mg/ml,
incubating with 50–69 and 2F5 at 2 mg/ml, applying anti-human alkaline phospha-
tase-conjugated secondary antibody (Life Technologies, Grand Island, NY) diluted
15500, then adding PnPP substrate (Sigma-Aldrich, St. Louis, MO). Plate readings
were done at 405 nm.
2D histogram segmentation by gradient intensity-based region growing. In order
to separate densities with low gradient intensities, representing structurally labile
regions, from more structurally rigid regions, we performed edge detection using
gradient magnitude calculation and scatterplot region growing to generate a 2D
histogramusing BioImageXD (University of Jyva¨skyla¨, University of Turku, Finland).
Regions were selected to differentiate from low and high gradient magnitudes.
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